These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 53469)

  • 21. Fatty-acid composition of lecithin fraction of mucus in cystic fibrosis.
    Sanjurjo P; Allue X; Rodriguez-Soriano J
    Lancet; 1977 Apr; 1(8014):572. PubMed ID: 66515
    [No Abstract]   [Full Text] [Related]  

  • 22. Essential fatty acid status and fluidity of plasma phospholipids in cystic fibrosis infants.
    Lloyd-Still JD; Johnson SB; Holman RT
    Am J Clin Nutr; 1991 Dec; 54(6):1029-35. PubMed ID: 1957818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis.
    Strandvik B; Gronowitz E; Enlund F; Martinsson T; Wahlström J
    J Pediatr; 2001 Nov; 139(5):650-5. PubMed ID: 11713441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two cases of cystic fibrosis in Japanese children: studies on the essential fatty acid and prostaglandin metabolism.
    Igarashi N; Hashimoto H; Hiratani M; Taniguchi M; Kasahara Y; Sato T; Taniguchi N; Funabashi T; Okuda N; Yamashiro Y
    Acta Paediatr Jpn; 1989 Apr; 31(2):205-10. PubMed ID: 2516700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystic fibrosis and nutrition: linking phospholipids and essential fatty acids with thiol metabolism.
    Innis SM; Davidson AG
    Annu Rev Nutr; 2008; 28():55-72. PubMed ID: 18498235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current knowledge on fatty acids in cystic fibrosis.
    Christophe A; Robberecht E
    Prostaglandins Leukot Essent Fatty Acids; 1996 Sep; 55(3):129-38. PubMed ID: 8931108
    [No Abstract]   [Full Text] [Related]  

  • 27. Early onset of essential fatty acid deficiency in patients with cystic fibrosis receiving a semisynthetic diet.
    Parsons HG; Shillabeer G; Rademaker AW
    J Pediatr; 1984 Dec; 105(6):958-61. PubMed ID: 6502350
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis.
    Maqbool A; Schall JI; Garcia-Espana JF; Zemel BS; Strandvik B; Stallings VA
    J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):635-44. PubMed ID: 18955866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Δ5- and Δ6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosis.
    Njoroge SW; Seegmiller AC; Katrangi W; Laposata M
    Biochim Biophys Acta; 2011; 1811(7-8):431-40. PubMed ID: 21605700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung transplantation in cystic fibrosis normalizes essential fatty acid profiles.
    Witters P; Dupont L; Vermeulen F; Proesmans M; Cassiman D; Wallemacq P; De Boeck K
    J Cyst Fibros; 2013 May; 12(3):222-8. PubMed ID: 23102588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Essential fatty acid metabolism and requirements during development.
    Uauy R; Treen M; Hoffman DR
    Semin Perinatol; 1989 Apr; 13(2):118-30. PubMed ID: 2662412
    [No Abstract]   [Full Text] [Related]  

  • 32. Essential fatty acid deficiency in the rabbit as a model of nutritional impairment in cystic fibrosis. In vitro and in vivo effects on lung defense mechanisms.
    Harper TB; Chase HP; Henson J; Henson PM
    Am Rev Respir Dis; 1982 Sep; 126(3):540-7. PubMed ID: 7125341
    [No Abstract]   [Full Text] [Related]  

  • 33. Triglyceride levels after Intralipid infusion in children with cystic fibrosis.
    Allué X; Sanjurjo P
    Pediatrics; 1978 Jun; 61(6):924-5. PubMed ID: 97619
    [No Abstract]   [Full Text] [Related]  

  • 34. Essential fatty acids and their derivatives.
    McCowen KC; Bistrian BR
    Curr Opin Gastroenterol; 2005 Mar; 21(2):207-15. PubMed ID: 15711215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy.
    Aldámiz-Echevarría L; Prieto JA; Andrade F; Elorz J; Sojo A; Lage S; Sanjurjo P; Vázquez C; Rodríguez-Soriano J
    Pediatr Res; 2009 Nov; 66(5):585-9. PubMed ID: 19851226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Essential fatty acid metabolism in infants.
    Innis SM; Hrboticky N; Foote KD
    Nutrition; 1989; 5(4):256-8. PubMed ID: 2520304
    [No Abstract]   [Full Text] [Related]  

  • 37. Cystic fibrosis-related dyslipidemia.
    Alves Cde A; Lima DS
    J Bras Pneumol; 2008 Oct; 34(10):829-37. PubMed ID: 19009217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatty acids, alpha-fetoprotein, and cystic fibrosis.
    Mizejewski GJ; Pass KA
    Pediatrics; 2001 Dec; 108(6):1370-3. PubMed ID: 11731663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The essential fatty acid deficient chicken as a model for cystic fibrosis.
    Craig-Schmidt MC; Faircloth SA; Teer PA; Weete JD; Wu CY
    Am J Clin Nutr; 1986 Dec; 44(6):816-24. PubMed ID: 3466523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephrolithiasis in cystic fibrosis.
    Strandvik B; Hjelte L
    Acta Paediatr; 1993 Mar; 82(3):306-7. PubMed ID: 8495090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.